Fennec Pharmaceuticals Inc (FRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Operating Expenses | 2,877 | 1,931 | 3,620 | 3,438 | 4,604 |
| Operating Income | -2,877 | -1,931 | -3,620 | -3,438 | -4,604 |
| Other Income | 701 | 3,776 | -1,543 | 8,123 | 4,604 |
| Pre-tax Income | -2,176 | 1,845 | -5,163 | 4,685 | N/A |
| Net Income Continuous | -2,176 | 1,845 | -5,163 | 4,685 | -7,823 |
| Net Income | $-2,176 | $1,845 | $-5,163 | $4,685 | $-7,823 |
| EPS Basic Total Ops | -0.22 | 0.18 | -0.63 | 0.60 | -1.25 |
| EPS Basic Continuous Ops | -0.22 | 0.18 | -0.63 | 0.60 | -1.25 |
| EPS Diluted Total Ops | -0.22 | 0.18 | -0.63 | 0.57 | -1.25 |
| EPS Diluted Continuous Ops | -0.22 | 0.18 | -0.63 | 0.57 | -1.25 |
| EBITDA(a) | $-2,877 | $1,845 | $-5,163 | $4,685 | $-4,604 |